Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 257

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Autonomic imbalance, hypertension, and cardiovascular risk

BROOK, R·2000·American Journal of Hypertension

Abstract

It is clear from many large randomized trials and from the metaanalyses published in the early 1990s1,2 that medication treatment of hypertension can be fully protective in reducing stroke risk. Unfortunately, the cardioprotective value of blood pressure therapy is less encouraging. Only with the use of low-dose diuretic therapy in the elderly3 has the reduction in cardiac morbidity approached the expected derived benefit from blood pressure lowering. In general, hypertension treatment has been unable to satisfactorily reduce cardiac morbidity and mortality.4 Several theories have sought to explain this apparent incongruity between our ability to lower blood pressure yet not adequately improve hypertension-related cardiovascular risk. Suboptimal control of blood pressure itself may be a contributing factor. This is underscored by the National Health and Nutrition Examination Study (NHANES) data,5 the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure (JNC VI),6 and similar publications in other industrialized countries, such as in Canada.7 Our failure to adequately control blood pressure cannot be explained by transient office-induced pressure elevations,8 but is more likely due to a lack of physician aggressiveness.9 This is despite strong evidence that aggressive therapy is both safe and can be particularly effective, as exemplified by patients with diabetes.10 Alternatively, blood pressure medications themselves have been blamed. Most older drugs—diuretics and β-blockers—disrupt and may worsen many cardiovascular-related metabolic factors, particularly lipids and insulin resistance,11 and both may activate the sympathetic nervous system.12 A large host of third-generation hypertension trials are underway to test the potential superior effectiveness of newer medications in cardiovascular protection.13 Unfortunately, the first of these trials, the Captopril Prevention Project (CAPP), failed to demonstrate superior cardiac risk reduction from captopril beyond atenolol despite a lower incidence of diabetes with captopril.14

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0895-7061(00)00228-4

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 126 references

Cited by

See all 257

Metadata

Authors
BROOK, R.
Venue
American Journal of Hypertension
Published
2000-06
Volume
13
Issue
6
Pages
S112-S122
ISSN
0895-7061 (ISSN-L)
OpenAlex
W2006273510
Cited by
257
References
126
FWCI
2.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autonomic imbalance, hypertension, and cardiovascular risk. https://app.cochat.ai/papers/10.1016/s0895-7061(00)00228-4
The paper
BROOK, R. (2000). Autonomic imbalance, hypertension, and cardiovascular risk. American Journal of Hypertension. https://doi.org/10.1016/s0895-7061(00)00228-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.